Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway
Molecules · 2024
DOI: 10.3390/molecules29204957 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Siqi Deng und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China. Hauptthemen laut MEDLINE: Apoptosis, Pentacyclic Triterpenes, Antineoplastic Agents, Mitochondria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for Education Department of Heilongjiang Province, Fundamental Research Funds for the Education Department of Heilongjiang Province.
Abstract (Originalsprache)
To improve the potential of lupeol against cancer cells, a privileged structure, thiazolidinedione, was introduced into its C-3 hydroxy group with ester, piperazine-carbamate, or ethylenediamine as a linker, and three series of thiazolidinedione-conjugated compounds (6a–i, 9a–i, and 12a–i) were prepared. The target compounds were evaluated for their cytotoxic activities against human lung cancer A549, human breast cancer MCF-7, human hepatocarcinoma HepG2, and human hepatic LO2 cell lines, and the results revealed that most of the compounds displayed improved potency over lupeol. Compound 12i exhibited significant activity against the HepG2 cell line, with an IC50 value of 4.40 μM, which is 9.9-fold more potent than lupeol (IC50 = 43.62 μM). Mechanistic studies suggested that 12i could induce HepG2 cell apoptosis, as evidenced by AO/EB staining and annexin V-FITC/propidium iodide dual staining assays. Western blot analysis suggested that compound 12i can upregulate Bax expression, downregulate Bcl-2 expression, and activate the mitochondria-mediated apoptotic pathway. Collectively, compound 12i is worthy of further investigation to support the discovery of effective agents against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China.
- Research Institute of Medicine & Pharmacy, Qiqihar Medical University, Qiqihar 161006, China.
ORCID-Profile: Ming Bu
Förderung
- Fundamental Research Funds for Education Department of Heilongjiang Province
- Fundamental Research Funds for the Education Department of Heilongjiang Province
Zitieren
APA
Deng, S., Zhao, Y., Guo, X., Hong, X., Li, G., Wang, Y., Li, Q., Bu, M., & Wang, M. (2024). Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway. Molecules. https://doi.org/10.3390/molecules29204957
Vancouver
Deng S, Zhao Y, Guo X, Hong X, Li G, Wang Y, et al. Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway. Molecules. 2024. doi:10.3390/molecules29204957
BibTeX
@article{Deng2024,
author = {Deng, Siqi and Zhao, Yinxu and Guo, Xiaoshan and Hong, Xian and Li, Gang and Wang, Yuchun and Li, Qingyi and Bu, Ming and Wang, Ming},
title = {Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29204957}
}
EUVIMED